Combination antiemetic therapy with aprepitant/fosaprepitant in patients with colorectal cancer receiving oxaliplatin-based chemotherapy (SENRI trial): a multicentre, randomised, controlled phase 3 trial.
暂无分享,去创建一个
Y. Ohno | Y. Doki | M. Mori | I. Takemasa | T. Mizushima | M. Sekimoto | Y. Miyake | Hirofumi Yamamoto | D. Sakai | T. Kudo | T. Satoh | J. Nishimura | H. Takemoto | M. Uemura | R. Nezu | T. Hata | M. Fukunaga | M. Yasui | Yoshihito Ide | Shunji Morita | K. Nakata | T. Fukuzaki